Edna Maneval

Directeur Technique/Scientifique/R&D chez ORIC PHARMACEUTICALS, INC.

64 ans

Health Technology

Consumer Services

Postes actifs de Edna Maneval

Sociétés	Poste	Début	Fin
ORIC PHARMACEUTICALS, INC.	Directeur Technique/Scientifique/R&D	01/03/2019	-

Sociétés	Poste	Début	Fin
IGNYTA INC	Corporate Officer/Principal	-	01/01/2018
Seragon Pharmaceuticals, Inc. Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA.	Corporate Officer/Principal	-	01/01/2014
Aragon Pharmaceuticals, Inc. Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA.	Corporate Officer/Principal	-	01/01/2013

University of Southern California

Doctorate Degree

Internationale

Etats-Unis

Opérationnelle

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	1
Doctorate Degree	1

Sectorielle

Health Technology	5
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
ORIC PHARMACEUTICALS, INC.	Health Technology

Entreprise privées	3
Ignyta, Inc. Ignyta, Inc. BiotechnologyHealth Technology Ignyta, Inc. operates as a medicine biotechnology company. The firm engages in the discovering, acquiring, developing and commercializing targeted new drugs for cancer patients. The company was founded by Jonathan E. Lim on September 13, 2011 and is headquartered in South San Francisco, CA.	Health Technology
Aragon Pharmaceuticals, Inc. Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA.	Health Technology
Seragon Pharmaceuticals, Inc. Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA.	Health Technology